WILMINGTON, Mass., Sept. 4, 2014 /PRNewswire/ -- Implant Sciences
Corporation (OTCQB: IMSC), a high technology supplier of systems
and sensors for homeland security and defense markets, announced
today it has sold 43 of its QS-H150 Explosives Trace Detection
systems to customers in China.
Organizations purchasing the systems include a police department
and a mass transit authority.
"China has always been a strong
market for Implant Sciences with police departments and mass
transit authorities being some of the oldest and largest customers.
These organizations have purchased hundreds of units over the past
several years, and they continue to ask for the QS-H150 over the
competition, including domestically produced systems," stated Dr.
Darryl Jones, Implant Sciences' Vice
President of Global Sales and Marketing. "That level of product
loyalty speaks volumes about the performance and reliability of our
technology."
About the QS-H150 Handheld Explosives Trace Detector
The QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology,
providing fast, accurate detection of trace amounts of a wide
variety of military, commercial, and homemade explosives. Built
with no radioactive materials and featuring a low-maintenance,
self-calibrating, and self-clearing design, the QS-H150 provides
very high levels of operational availability. The QS-H150 has been
proven to perform well in a wide variety of temperatures and
challenging environments, from humid jungles to dry, sand swept
deserts.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing
advanced detection capabilities to counter and eliminate the
ever-evolving threats from explosives and drugs. The Company's team
of dedicated trace detection experts has developed proprietary
technologies used in its commercial products, thousands of which
have been sold across more than 50 countries worldwide. Implant
Sciences is only the third manufacturer, and the sole
American-owned company, to currently have an ETD system named as a
Qualified Product by the US Transportation Security Administration.
The Company's ETDs have received approvals and certifications from
several international regulatory agencies including the TSA in the
U.S., STAC in France, the German
Ministry of the Interior, and the Ministry of Public Safety in
China. It also received a GSN 2013
Homeland Security Award for "Best Explosives Detection
Solution". All Implant Sciences products are recognized as
Qualified Anti-Terrorism Technologies by the Department of Homeland
Security. For further details on the Company and its products,
please visit the Company's website at www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking
statements," as that term is defined in the Private Securities
Litigation Reform Act of 1995. Such statements are based on
management's current expectations and are subject to risks and
uncertainties that could cause the Company's actual results to
differ materially from the forward-looking statements. Such risks
and uncertainties include, but are not limited to, the risks that
there is no guaranty that the Transportation Security
Administration (TSA) or any other U.S. or foreign government and
law enforcement agencies or commercial consumers will purchase any
of our explosives detection products or that any new products we
may develop will be accepted by the TSA or by such other
governments, agencies or consumers; economic, political and other
risks associated with international sales and operations could
adversely affect our sales; our business is subject to intense
competition and rapid technological change, and our success will
depend on our ability to develop and introduce new products; and
other risks and uncertainties described in our filings with the
Securities and Exchange Commission, including our most recent Forms
10-K, 10-Q and 8-K. Such statements are based on management's
current expectations and assumptions which could differ materially
from the forward-looking statements.
Contact:
Implant Sciences Corporation
Company Contact:
Glenn Bolduc, CEO
978-752-1700
or
Investor Contact:
Laurel Moody
646-810-0608
SOURCE Implant Sciences Corporation